Tag: Clots
Non-O Blood Type Time-Dependent Predictor of VTE in Cancer
In patients with intermediate or low thrombotic risk tumor types, non-O blood type linked to increased VTE risk
Cardiovascular Mortality Down Among Dialysis Patients
Greater declines seen for myocardial infarction, stroke, and pulmonary embolism among dialysis patients than general population
COVID-19 Linked to Increased Risk for DVT, PE, Bleeding
Rate ratios were highest for critical COVID-19, and during first versus second and third pandemic waves in Sweden
Risk for Blood Clots After COVID-19 Vaccination Explored
Two studies show increase in intracranial venous thrombosis, thrombocytopenia for those younger than 70 years and in CVST after ChAdOx1-S
Exercise May Lower Clotting Risk in Patients With NASH
Exercise benefits extend beyond liver-related outcomes, independent of weight loss or dietary change
Scientists Report ‘Rogue Antibodies’ Behind Severe Clotting With COVID-19
Study authors suggest future research assess the potential benefits of screening COVID-19 patients for antiphospholipids and other autoantibodies
DOACs Cut Recurrent VTE in Adults With Cancer-Related Thrombosis
Direct oral anticoagulants reduce recurrent VTE events by 41 percent, with no significant increase in major bleeding, compared to dalteparin
Smartphone System Can Assess Blood Clotting From Single Drop
Micro-mechanical system using vibration motor and camera on smartphones can compute the PT/INR
Bleeding Events Up With Full-Dose Thromboprophylaxis in COVID-19
Almost all hospitalized COVID-19 patients with a bleeding event were receiving mechanical ventilation, full-dose anticoagulation
Thrombosis, Thrombocytopenia Syndrome Up After Ad26.COV2.S
Reporting rates 3.83 per million vaccine doses for Ad26.COV2.S versus 0.00855 per million for mRNA-based vaccines
